A detailed history of National Bank Of Canada transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 2,000 shares of PLSE stock, worth $29,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$29,120
Previous $17,000 29.41%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$4.03 - $8.73 $4,030 - $8,730
-1,000 Reduced 33.33%
2,000 $8,000
Q2 2023

Jul 26, 2023

BUY
$3.67 - $8.64 $3,670 - $8,640
1,000 Added 50.0%
3,000 $21,000
Q4 2022

Jan 24, 2023

BUY
$1.73 - $2.89 $3,460 - $5,780
2,000 New
2,000 $0

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $541M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.